| | | 42237 | | 09.07.1980 | | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | | | | | | | | | | | | | | | 01.05.2004 | | | | |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Gaviscon | Liquidum | Suspension (oral) (Natrii Hydrogenocarbonas 170 mg, Calcii Carbonas 150 mg, Aluminii Oxidum Hydricum 200 mg, Natrii Alginas 500 mg) | A02AX | PI |
|
|
